Case Report on Primary Cardiac Angiosarcoma
Author Information
Author(s): Dhatri Kodali, Seetharaman Kala
Primary Institution: University of Minnesota
Hypothesis
The patient might have responded to liposomal doxorubicin because of its unique activity in angiosarcoma in comparison to other sarcomas.
Conclusion
This case provides further support for the role of liposomal doxorubicin in the treatment of primary cardiac angiosarcoma.
Supporting Evidence
- Primary cardiac sarcoma is very rare, with an incidence of 0.0001%.
- The patient had a significant response to liposomal doxorubicin after three cycles.
- Most patients with cardiac sarcoma present with metastasis at diagnosis.
Takeaway
A woman with a rare heart tumor was treated with a special type of chemotherapy that worked well for her, but she eventually got worse and passed away.
Methodology
The patient was treated with liposomal doxorubicin and underwent imaging to assess tumor response.
Limitations
The rarity of cardiac angiosarcoma limits the generalizability of findings.
Participant Demographics
The patient was a 66-year-old woman.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website